Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1110-1117

  Kara, Ervin E ^a   Comerford, Iain ^a   Bastow, Cameron R ^a   Fenix, Kevin A ^a   Litchfield, Wendel ^a   Handel, Tracy M ^b   McColl, Shaun R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 9;

ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TH9 CELL;

ANIMALS; AUTOIMMUNITY; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-9; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CCR3; RECEPTORS, CCR6; RECEPTORS, CXCR3; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84880675210     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203089     Document Type: Article

References (50)

1. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factorbeta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
2. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(2) effector T cells. Nat. Immunol. 9: 1347-1355.
3. Jabeen, R., and M. H. Kaplan. 2012. The symphony of the ninth: the development and function of Th9 cells. Curr. Opin. Immunol. 24: 303-307.
4. McMillan, S. J., B. Bishop, M. J. Townsend, A. N. McKenzie, and C. M. Lloyd. 2002. The absence of interleukin 9 does not affect the development of allergeninduced pulmonary inflammation nor airway hyperreactivity. J. Exp. Med. 195: 51-57.
5. Cheng, G., M. Arima, K. Honda, H. Hirata, F. Eda, N. Yoshida, F. Fukushima, Y. Ishii, and T. Fukuda. 2002. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166: 409-416.
6. Kung, T. T., B. Luo, Y. Crawley, C. G. Garlisi, K. Devito, M. Minnicozzi, R. W. Egan, W. Kreutner, and R. W. Chapman. 2001. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 25: 600-605.
7. Angkasekwinai, P., S. H. Chang, M. Thapa, H. Watarai, and C. Dong. 2010. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11: 250-256.
8. Monteyne, P., J. C. Renauld, J. Van Broeck, D. W. Dunne, F. Brombacher, and J. P. Coutelier. 1997. IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 159: 2616-2623.
9. Gessner, A., H. Blum, and M. Röllinghoff. 1993. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189: 419-435.
10. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
11. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
12. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
13. Li, H., B. Nourbakhsh, B. Ciric, G. X. Zhang, and A. Rostami. 2010. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J. Immunol. 185: 4095-4100.
14. Li, H., B. Nourbakhsh, M. Cullimore, G. X. Zhang, and A. Rostami. 2011. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur. J. Immunol. 41: 2197-2206.
15. Nowak, E. C., C. T. Weaver, H. Turner, S. Begum-Haque, B. Becher, B. Schreiner, A. J. Coyle, L. H. Kasper, and R. J. Noelle. 2009. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206: 1653-1660.
16. Tan, C., M. K. Aziz, J. D. Lovaas, B. P. Vistica, G. Shi, E. F. Wawrousek, and I. Gery. 2010. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J. Immunol. 185: 6795-6801.
17. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
18. Viola, A., B. Molon, and R. L. Contento. 2008. Chemokines: coded messages for T-cell missions. Front. Biosci. 13: 6341-6353.
19. He, S. H., Z. Q. Liu, X. Chen, C. H. Song, L. F. Zhou, W. J. Ma, L. Cheng, Y. Du, S. G. Tang, and P. C. Yang. 2011. IL-9(+) IL-10(+) T cells link immediate allergic response to late phase reaction. Clin. Exp. Immunol. 165: 29-37.
20. Kohler, R. E., I. Comerford, S. Townley, S. Haylock-Jacobs, I. Clark-Lewis, and S. R. McColl. 2008. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 18: 504-516.
21. Liston, A., R. E. Kohler, S. Townley, S. Haylock-Jacobs, I. Comerford, A. C. Caon, J. Webster, J. M. Harrison, J. Swann, I. Clark-Lewis, et al. 2009. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J. Immunol. 182: 3121-3130.
22. White, J. R., J. M. Lee, K. Dede, C. S. Imburgia, A. J. Jurewicz, G. Chan, J. A. Fornwald, D. Dhanak, L. T. Christmann, M. G. Darcy, et al. 2000. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J. Biol. Chem. 275: 36626-36631.
23. Haylock-Jacobs, S., I. Comerford, M. Bunting, E. Kara, S. Townley, M. Klingler-Hoffmann, B. Vanhaesebroeck, K. D. Puri, and S. R. McColl. 2011. PI3Kd drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J. Autoimmun. 36: 278-287.
24. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134.
25. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
26. Yamazaki, T., X. O. Yang, Y. Chung, A. Fukunaga, R. Nurieva, B. Pappu, N. Martin-Orozco, H. S. Kang, L. Ma, A. D. Panopoulos, et al. 2008. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181: 8391-8401.
27. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156: 2095-2103.
28. Noelle, R. J., and E. C. Nowak. 2010. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10: 683-687.
29. Mori, A., K. Ogawa, K. Someya, Y. Kunori, D. Nagakubo, O. Yoshie, F. Kitamura, T. Hiroi, and O. Kaminuma. 2007. Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists. Int. Immunol. 19: 913-921.
30. Francis, J. N., I. Sabroe, C. M. Lloyd, S. R. Durham, and S. J. Till. 2008. Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin. Exp. Immunol. 152: 440-447.
31. Pease, J. E. 2006. Asthma, allergy and chemokines. Curr. Drug Targets 7: 3-12.
32. McColl, S. R., S. Mahalingam, M. Staykova, L. A. Tylaska, K. E. Fisher, C. A. Strick, R. P. Gladue, K. S. Neote, and D. O. Willenborg. 2004. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands. Lab. Invest. 84: 1418-1429.
33. Kohler, R. E., A. C. Caon, D. O. Willenborg, I. Clark-Lewis, and S. R. McColl. 2003. A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170: 6298-6306.
34. Viola, A., and A. D. Luster. 2008. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48: 171-197.
35. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
36. Colantonio, L., A. Iellem, B. Clissi, R. Pardi, L. Rogge, F. Sinigaglia, and D. D'Ambrosio. 1999. Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells. Blood 94: 2981-2989.
37. D'Ambrosio, D., A. Iellem, R. Bonecchi, D.Mazzeo, S. Sozzani, A.Mantovani, and F. Sinigaglia. 1998. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161: 5111-5115.
38. Comerford, I., M. Bunting, K. Fenix, S. Haylock-Jacobs, W. Litchfield, Y. Harata-Lee, M. Turvey, J. Brazzatti, C. Gregor, P. Nguyen, et al. 2010. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays 32: 1067-1076.
39. Lim, H. W., J. Lee, P. Hillsamer, and C. H. Kim. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180: 122-129.
40. Menning, A., U. E. Höpken, K. Siegmund, M. Lipp, A. Hamann, and J. Huehn. 2007. Distinctive role of CCR7 in migration and functional activity of naive-And effector/memory-like Treg subsets. Eur. J. Immunol. 37: 1575-1583.
41. Oh, C. K., D. Raible, G. P. Geba, and N. A. Molfino. 2011. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm. Allergy Drug Targets 10: 180-186.
42. Ye, Z. J., M. L. Yuan, Q. Zhou, R. H. Du, W. B. Yang, X. Z. Xiong, J. C. Zhang, C. Wu, S. M. Qin, and H. Z. Shi. 2012. Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS ONE 7: e31710.
43. Dodd, J. S., E. Lum, J. Goulding, R. Muir, J. Van Snick, and P. J. Openshaw. 2009. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J. Immunol. 183: 7006-7013.
44. Zhou, Y., Y. Sonobe, T. Akahori, S. Jin, J. Kawanokuchi, M. Noda, Y. Iwakura, T. Mizuno, and A. Suzumura. 2011. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J. Immunol. 186: 4415-4421.
45. Gounni, A. S., Q. Hamid, S. M. Rahman, J. Hoeck, J. Yang, and L. Shan. 2004. IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J. Immunol. 173: 2771-2779.
46. Baraldo, S., D. S. Faffe, P. E. Moore, T.Whitehead, M.McKenna, E. S. Silverman, R. A. Panettieri, Jr., and S. A. Shore. 2003. Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am. J. Physiol. Lung Cell.Mol. Physiol. 284: L1093-L1102.
47. Wilhelm, C., K. Hirota, B. Stieglitz, J. Van Snick, M. Tolaini, K. Lahl, T. Sparwasser, H. Helmby, and B. Stockinger. 2011. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12: 1071-1077.
48. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
49. Pham, T. H., T. Okada, M. Matloubian, C. G. Lo, and J. G. Cyster. 2008. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28: 122-133.
50. Bolli, M. H., C. Lescop, and O. Nayler. 2011. Synthetic sphingosine 1-phosphate receptor modulators-opportunities and potential pitfalls. Curr. Top. Med. Chem. 11: 726-757.